ZyVersa Therapeutics Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.
The company stated in the following news article that they use animals for drug testing.
“Likewise, our previous work has demonstrated the therapeutic potential of inhibiting ASC in animal models representing a variety of diseases, including multiple sclerosis, acute respiratory distress syndrome, traumatic brain injury, spinal cord injury, and age-related inflammation associated with conditions such as Alzheimer’s disease.” Read the following article
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Company Website: https://www.zyversa.com